Market Currents
Discovery Laboratories (DSCO -1%) is outperforming the averages this morning after saying it's...
-
Tuesday, September 6, 2011, 1:11 PM ETDiscovery Laboratories (DSCO -1%) is outperforming the averages this morning after saying it's responded to FDA quality control concerns regarding Surfaxin, its experimental preventative drug for respiratory distress syndrome in premature infants.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
